EATRIS, the European Infrastructure for Translational Medicine, is an EU-funded program that facilitates scientific collaboration amongst public…

Dr. Grace Zhou, dean of SIIBR, discusses the Institute’s priorities, the benefits of being located in Shenzhen and the city’s potential as a…

Keith Thompson, CEO of the Cell & Gene Therapy Catapult, one of a number of Catapult institutions in the UK designed to help commercialize…

Tony Jones, CEO of One Nucleus, a life sciences membership organization centered on the Greater London-Cambridge-East of England corridor, discusses…

Prof. Luca G. Guidotti discusses the esteemed positioning of San Raffaele within the global scientific community, their core mission of translational…

The Director-General of the Gustave Roussy Institute, a top cancer institute in Europe, talks about the revamping of their clinical research…

The president of the Institut Pasteur talks about how they must build on their differentiating factors, with a focus on interdisciplinary research,…

The Director of the CNCR and the person in charge of the industrial sector, talk about the fragmented nature of French clinical research funding, why…

Lygature is the new name of TI Pharma and CTMM, two internationally renowned public-private-partnerships turned non-for-profit partnership drivers.…

Founder of Promedon Marcelo Olmedo discusses innovation in Cordoba, and the birth and success of Promedon, a flagship company of the region.  …

The executive director of Latin America’s largest plasma fractionation plant, a publicly-funded laboratory within the 400 year old National…